Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Global drug screening market to grow at a 16.16% CAGR to USD 20.86B by 2031, driven by demand for rapid testing and advanced analytical technologies.
-
PHILADELPHIA, April 02, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against Vital Farms, Inc. (NASDAQ: VITL) (“Vital Farms” or the...
-
Dose-Dependent Efficacy Results: As of the latest data cut, muzastotug achieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement...
-
Bunzl PLC’s North American operations earns EcoVadis Gold Medal for sustainability performance, placing it among top 5% of companies assessed globally.
-
Company enters 2026 with reduced leverage, extended debt maturity and added liquidity Pursues top-line stabilization and margin expansion with strategic brand repositioning to Beyond The Plant...
-
Regina, Sask., March 31, 2026 (GLOBE NEWSWIRE) -- Today, Protein Industries Canada announced a new project in partnership with AGT Foods and Sweet Nutrition aimed at advancing the next generation of...
-
Alexandria, VA, March 31, 2026 (GLOBE NEWSWIRE) -- Today, United Way Worldwide released its annual 211 Impact Survey – collecting data from 211 contact centers serving all 50 states and Puerto Rico...
-
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, March 31, 2026 (GLOBE NEWSWIRE) --...
-
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed...
-
AAD : Sanofi présente de nouveaux résultats de phase 3 pour l'amlitelimab dans la dermatite atopique lors d'une session de dernière minute Dans les études de phase 3 COAST 1, COAST 2 et SHORE,...